US Stock MarketDetailed Quotes

Vera Therapeutics (VERA)

Watchlist
  • 37.690
  • -0.700-1.82%
Close Apr 24 16:00 ET
  • 37.690
  • 0.0000.00%
Post 20:01 ET
2.70BMarket Cap-8.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vera Therapeutics (VERA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
88.71%315.47M
92.60%94.21M
68.53%83.93M
114.61%80.14M
83.83%57.19M
63.87%167.17M
80.98%48.91M
128.91%49.8M
69.97%37.34M
-0.47%31.11M
Selling and administrative expenses
144.44%100.22M
124.17%34.9M
189.44%27.46M
173.23%21.95M
101.16%15.92M
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
28.65%7.91M
-Selling and marketing expense
----
----
142,525.00%5.71M
190,450.00%3.81M
5,038.46%1.34M
----
----
--4K
--2K
--26K
-General and administrative expense
144.44%100.22M
193.28%45.75M
129.40%21.75M
125.84%18.14M
84.88%14.58M
72.35%41M
149.86%15.6M
67.66%9.48M
39.92%8.03M
28.23%7.89M
Research and development costs
70.61%215.26M
77.86%59.31M
40.08%56.47M
98.54%58.2M
77.92%41.28M
61.29%126.17M
60.44%33.35M
150.40%40.31M
80.59%29.31M
-7.60%23.2M
Operating profit
-88.71%-315.47M
-92.60%-94.21M
-68.53%-83.93M
-114.61%-80.14M
-83.83%-57.19M
-63.87%-167.17M
-80.98%-48.91M
-128.91%-49.8M
-69.97%-37.34M
0.47%-31.11M
Net non-operating interest income expense
29.49%16.95M
-24.60%3.61M
33.66%3.78M
39.29%4.45M
124.30%5.11M
212.14%13.09M
430.09%4.79M
132.51%2.83M
140.91%3.19M
204.41%2.28M
Non-operating interest income
18.18%24.48M
-17.20%5.52M
20.48%5.74M
23.82%6.32M
64.98%6.91M
159.61%20.71M
239.95%6.66M
120.62%4.76M
127.96%5.1M
157.92%4.19M
Non-operating interest expense
-1.25%7.53M
1.76%1.9M
1.24%1.96M
-1.99%1.87M
-5.98%1.79M
101.43%7.63M
77.18%1.87M
105.30%1.94M
109.19%1.91M
118.08%1.91M
Other net income (expense)
-156.28%-1.09M
-172.06%-503K
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-8.28%443K
2.05%449K
Gain on sale of security
----
----
----
----
----
----
----
----
75.00%-7K
-300.00%-4K
Other non- operating income (expenses)
-156.28%-1.09M
-172.06%-503K
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-13.31%443K
1.81%449K
Income before tax
-96.92%-299.61M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.42M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
Income tax
0.00%1K
0.00%1K
Net income
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
Net income continuous Operations
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
Minority interest income
Net income attributable to the parent company
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-96.92%-299.62M
-109.78%-91.1M
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
Basic earnings per share
-69.45%-4.66
-93.06%-1.39
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
Diluted earnings per share
-69.45%-4.66
-93.06%-1.39
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 88.71%315.47M92.60%94.21M68.53%83.93M114.61%80.14M83.83%57.19M63.87%167.17M80.98%48.91M128.91%49.8M69.97%37.34M-0.47%31.11M
Selling and administrative expenses 144.44%100.22M124.17%34.9M189.44%27.46M173.23%21.95M101.16%15.92M72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M28.65%7.91M
-Selling and marketing expense --------142,525.00%5.71M190,450.00%3.81M5,038.46%1.34M----------4K--2K--26K
-General and administrative expense 144.44%100.22M193.28%45.75M129.40%21.75M125.84%18.14M84.88%14.58M72.35%41M149.86%15.6M67.66%9.48M39.92%8.03M28.23%7.89M
Research and development costs 70.61%215.26M77.86%59.31M40.08%56.47M98.54%58.2M77.92%41.28M61.29%126.17M60.44%33.35M150.40%40.31M80.59%29.31M-7.60%23.2M
Operating profit -88.71%-315.47M-92.60%-94.21M-68.53%-83.93M-114.61%-80.14M-83.83%-57.19M-63.87%-167.17M-80.98%-48.91M-128.91%-49.8M-69.97%-37.34M0.47%-31.11M
Net non-operating interest income expense 29.49%16.95M-24.60%3.61M33.66%3.78M39.29%4.45M124.30%5.11M212.14%13.09M430.09%4.79M132.51%2.83M140.91%3.19M204.41%2.28M
Non-operating interest income 18.18%24.48M-17.20%5.52M20.48%5.74M23.82%6.32M64.98%6.91M159.61%20.71M239.95%6.66M120.62%4.76M127.96%5.1M157.92%4.19M
Non-operating interest expense -1.25%7.53M1.76%1.9M1.24%1.96M-1.99%1.87M-5.98%1.79M101.43%7.63M77.18%1.87M105.30%1.94M109.19%1.91M118.08%1.91M
Other net income (expense) -156.28%-1.09M-172.06%-503K-139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-8.28%443K2.05%449K
Gain on sale of security --------------------------------75.00%-7K-300.00%-4K
Other non- operating income (expenses) -156.28%-1.09M-172.06%-503K-139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-13.31%443K1.81%449K
Income before tax -96.92%-299.61M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.42M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M
Income tax 0.00%1K0.00%1K
Net income -96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M
Net income continuous Operations -96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M
Minority interest income
Net income attributable to the parent company -96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -96.92%-299.62M-109.78%-91.1M-72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M
Basic earnings per share -69.45%-4.66-93.06%-1.39-48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.56
Diluted earnings per share -69.45%-4.66-93.06%-1.39-48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -